Approval · Notice of Compliance 5443 · 1994
NAPROSYN: Notice of Compliance 5443
Issued April 27, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5443
- Date
- April 27, 1994
- Company
- Syntex Inc.Luis Guillon, Buenos Aires, Argentina
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing of active ingredient
- Therapeutic class
- Anti-inflammatory agent with analgesic and antipyretic properties
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAPROSYN | Not yet assigned | — |